Heidelberg Pharma Ag operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Heidelberg Pharma Ag with three other
companies in this sector in GERMANY :
sales of 10.63 million Euro [US$12.90 million]
of which 92%
Northern Data AG
(10.16 million Euro [US$12.33 million]
(2.20 million Euro [US$2.67 million]
Heidelberg Pharma Ag reported sales of 7.31 million Euro (US$8.87 million)
November of 2019.
increase of 99.3%
versus 2018, when the company's sales were 3.67 million Euro.
This was the third consecutive year of growth at Heidelberg Pharma Ag.